Medtronic obtains CE approval for LigaSure technology integration in robotic surgical system.
The latest advancements in surgical technology are on display at the Society of Robotic Surgery (SRS) 2025 Annual Meeting, with Medtronic leading the charge. The event, taking place in Strasbourg, France from July 16-20, will feature demonstrations and presentations showcasing the company's Hugo Robotic-Assisted Surgery (RAS) system.
One of the key developments is the recent CE Mark approval for the integration of Medtronic's LigaSure RAS vessel-sealing technology with the Hugo RAS system. This enhancement expands the system's capabilities for gynecologic, general, and urologic procedures across Europe[1][5].
Medtronic will also demonstrate telesurgery capabilities on the Hugo RAS system from its strategic training partner, the IRCAD facility. This demonstration is part of the company's push towards innovation in remote surgical procedures[1].
The Hugo RAS system is already in use across over 30 countries on five continents, supporting various procedures in urology, gynecology, and general surgery. Over 270 independent publications have supported its clinical use[1].
Looking ahead, Medtronic has submitted the Hugo RAS system for FDA review in the U.S., with an expected entry later in the company's current fiscal year. Initial indications will focus on urology, followed by planned expansions into hernia and gynecology procedures[1][4].
The SRS meeting will also feature a presentation on preliminary outcomes of hysterectomy for benign gynecologic conditions, based on a Medtronic-sponsored study of 112 Hugo RAS procedures across eight sites in Europe and Asia. Dr. Miguel Caceres, one of the first surgeons to use LigaSure RAS with the Hugo RAS system, will discuss his initial experience with the technology during a Medtronic-sponsored symposium at the meeting[1].
The demonstration will be followed by a panel discussion involving authors of the Technical Guidelines for Remote Robotic-Assisted Surgery. These advancements underscore Medtronic's commitment to advancing remote and robotic-assisted surgery, with a focus on expanding telesurgery capabilities and clinical applications of the Hugo RAS system[2].
The LigaSure RAS device, now integrated onto the Hugo RAS system, reliably seals vessels in approximately 2 seconds while minimising thermal spread to surrounding tissue[3]. The U.S. entrance for the Hugo RAS system is expected later in Medtronic's current fiscal year[6].
Dr. Francesco Fanfani, associate professor at Agostino Gemelli University Polyclinic, will present the data at SRS 2025 Annual Meeting. The paper supporting safe and scalable telesurgery, published in the Journal of World Surgery, reinforces Medtronic's commitment to innovation powered by human connection[7].
Sources: [1] Medtronic Press Release, "Medtronic to Demonstrate Telesurgery Capabilities and Present Clinical Data on Hugo RAS System at Society of Robotic Surgery 2025 Annual Meeting," 12 July 2025. [2] Medtronic Press Release, "Medtronic Secures CE Mark for LigaSure RAS Vessel-Sealing Technology on Hugo RAS System," 10 June 2025. [3] Medtronic Website, "LigaSure RAS," accessed 13 July 2025. [4] Medtronic Press Release, "Medtronic to Expand Hugo RAS System Installations and Training Programs in Korea," 20 May 2025. [5] Medtronic Press Release, "Medtronic Receives CE Mark for LigaSure RAS Vessel-Sealing Technology," 15 April 2025. [6] Medtronic Website, "Hugo RAS System," accessed 13 July 2025. [7] Journal of World Surgery, "Safe and Scalable Telesurgery: A Systematic Review," 1 March 2025.
Science and medical-conditions intertwine at the Society of Robotic Surgery (SRS) 2025 Annual Meeting, as a Medtronic-sponsored study showcases preliminary outcomes of hysterectomy for benign gynecologic conditions, based on 112 Hugo Robotic-Assisted Surgery (RAS) procedures across eight sites in Europe and Asia.
The integration of technology, particularly Medtronic's LigaSure RAS vessel-sealing technology with the Hugo RAS system, has expanded the system's capabilities for various health-and-wellness procedures across Europe, considering general-news reports about its recent CE Mark approval.
